You are here

Nepochatykh M.G., Safonova S.A., Pososhkov I.D., Bogdanova V.A., Nepochatykh A.V. On the issue of rehabilitation of children with chemotherapy-induced peripheral neuropathy

DOI: 10.34835/issn.2308-1961.2021.1.p265-271
On the issue of rehabilitation of children with chemotherapy-induced peripheral neuropathy
Marina Gennadievna Nepochatykh, the candidate of pedagogical sciences, senior lecturer, St. Petersburg State University of Economics; Svetlana Aleksandrovna Safonova, the candidate of medical sciences, Head of Department, St. Petersburg Publicly Funded Health Care Facility "Health Camp "Solnechnoe"; Igor Dmitrievich Pososhkov, the candidate of economical sciences, senior lecturer, Victoria Anatolyevna Bogdanova, the senior teacher, St. Petersburg State University of Economics; Alina Vadimovna Nepochatykh, Lesgaft National State University of Physical Education, Sport and Health, St. Petersburg

Chemotherapy-induced peripheral neuropathy (CIPN) is the most frequent complication of the treatment of malignant neoplasms in children. CIPN leads both to the child disability and to a decrease in the quality of life of the child and family members. Treatment of polyneuropathy is a complex and time-consuming process that includes both medication and non-medication methods. Many authors pay attention to the effectiveness of complex rehabilitation treatment, however, the lack of approved treatment standards, a convincing evidence base, and specially developed programs does not allow developing a unified approach to the rehabilitation of such patients. The article analyzes the existing programs and approach to the possibilities of rehabilitation of patients with CIPN.
Keywords: children, peripheral neuropathy, chemotherapy, pediatric oncology, CIPN, rehabilitation treatment.

  1. Rykov, M.Yu., Turabov, I.A., Punanov, Yu.A. and Safonova, S.A. (2019), “Analysis of the main indicators characterizing medical care for children with cancer in St. Petersburg and the Leningrad Oblast in 2013-2017”, Problems in Oncology, Vol. 65, No. 1, pp. 77-82.
  2. Zolotovskaya, I.A., Davydkin, I.L., Lokshtanova, T.M. and Orlov, A.E. (2018), “Clinical manifestations of polyneuropathy in cancer patients during chemotherapy and the possibility of their pharmacological correction”, The Russian Archives of Internal Medicine, No. 2, pp. 137-144.
  3. Nuvakhova, M.B. (2019) “Polyneuropathy: methods of treatment and rehabilitation”, Medical Sciences, No. 17, pp. 409-412.
  4. Kholodova, N.B., Sotnikov, V.M., Dobrovolskaya, N.Yu. and Ponkratova, Yu.A. (2013), “Features of clinical manifestations and treatment of polyneuropathy developed after chemotherapy”, S.S. Korsakov Journal of Neurology and Psychiatry, Vol. 113, No. 5. pp. 20-24.
  5. Vatutin, N.T., Sklyannaya, E.V., El-Khatib, M.A., Makarova, M.V. and Starchenko, S.V. (2016), “Peripheral polyneuropathies induced by various chemotherapeutic agents: current state of the problem”, Russian Journal of Hematology and Transfusiology, Vol. 61, No. 2, pp. 105-109.
  6. Vorobeva, L.A., Safonova, S.A., Dmitrieva, O.M., Zvyagintseva, D.A., Strelkova, T.V., Punanov, Yu.A. and Lavrik, N.P. (2015) “Sanatorium "Solnechnoye": possibilities of rehabilitation of children with malignant neoplasms”, Oncopediatrics, Vol. 2, No. 3, pp. 249.
  7. Smagulova, K., Khudaibergenova, M. and Abdrakhmanov, R. (2017), “Post-chemotherapy polyneuropathy”, The Oncology and Radiology of Kazakhstan, No. 4 (46), pp. 47-50.
  8. Shishkina, Е.S., Baidina, Т.V., Fokina, Е.S. and Minaeva, N.V. (2018), “Somatic and autonomic neuropathy at oncohematological diseases”, Medical Almanac, Vol. 5(56), pp. 112-116.
  9. Sharipova, M.G., Smirnov, D.S., Yakupov, M.R. ad Spichak, I.I. (2016), “Chemically induced polyneuropathy in children with oncological pathology”, Pediatric Bulletin of the South Ural, No. 1, pp. 53-61.
  10. Koneva, E.S., Bobkova, A.V., Shapovalenko, T.V., Lyadov. K.V. and Kotenko, K.V. (2018), “The effectiveness of the inclusion of complex rehabilitation programs into the treatment of chemically induced peripheral polyneuropathy”, Physiotherapist, No. 2, pp. 64-49.
Contact information:
Article arrived in edition 27.12.2020
Show full text